Quick Answer
ClearPoint Neuro, Inc. reported Common Stock Shares Outstanding of 29.37 million shares for the year ending 2025.
- ClearPoint Neuro, Inc. showed an increase of +6.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from ClearPoint Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: 41.95 million shares | Q3 2012: 47.84 million shares | Q1 2013: 57.32 million shares | Q2 2013: 57.79 million shares | Q3 2013: 58.48 million shares | Q1 2014: 58.92 million shares | Q2 2014: 58.96 million shares | Q3 2014: 58.99 million shares | Q1 2015: 74.88 million shares | Q2 2015: 74.91 million shares | Q3 2015: 74.97 million shares | Q1 2016: 91.92 million shares | Q2 2016: 2.40 million shares | Q3 2016: 3.61 million shares | Q1 2017: 3.62 million shares | Q2 2017: 10.34 million shares | Q3 2017: 10.34 million shares | Q1 2018: 10.83 million shares | Q2 2018: 11.01 million shares | Q3 2018: 11.02 million shares | Q1 2019: 11.07 million shares | Q2 2019: 13.69 million shares | Q3 2019: 14.99 million shares | Q1 2020: 15.51 million shares | Q2 2020: 15.51 million shares | Q3 2020: 15.88 million shares | Q1 2021: 20.68 million shares | Q2 2021: 22.32 million shares | Q3 2021: 22.86 million shares | Q1 2022: 23.71 million shares | Q2 2022: 24.48 million shares | Q3 2022: 24.50 million shares | Q1 2023: 24.58 million shares | Q2 2023: 24.63 million shares | Q3 2023: 24.63 million shares | Q1 2024: 27.42 million shares | Q2 2024: 27.59 million shares | Q3 2024: 27.59 million shares | Q1 2025: 27.98 million shares | Q2 2025: 28.42 million shares | Q3 2025: 28.43 million shares.
- Over the full 15 years of available data (2011 to 2025), ClearPoint Neuro, Inc.'s Common Stock Shares Outstanding has grown by 82.6%.
- Historical annual values: Fiscal year 2025: 29.37 million shares | Fiscal year 2024: 27.62 million shares | Fiscal year 2023: 24.65 million shares | Fiscal year 2022: 24.58 million shares | Fiscal year 2021: 23.67 million shares | Fiscal year 2020: 17.05 million shares | Fiscal year 2019: 15.24 million shares | Fiscal year 2018: 11.02 million shares | Fiscal year 2017: 10.69 million shares | Fiscal year 2016: 3.62 million shares | Fiscal year 2015: 2.28 million shares | Fiscal year 2014: 74.84 million shares | Fiscal year 2013: 58.54 million shares | Fiscal year 2012: 48.09 million shares | Fiscal year 2011: 16.08 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: